Form 8-K · Current report
News Corp 8-K, filed Jul 17, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000154
Summary
News Corp bought back 62,323 shares of its Class A common stock for approximately US$1.78 million on July 16, 2026 under its 2025 Repurchase Program, which authorizes up to US$1 billion in aggregate repurchases of its Nasdaq-listed Class A and Class B stock. To date the company has purchased roughly US$369.7 million worth of shares under the program, with Goldman Sachs & Co. LLC named as broker.
Key points
- News Corp repurchased 62,323 Class A shares on 16 July 2026 at prices between US$28.22 and US$28.68 per share.
- Cumulative repurchases under the 2025 Repurchase Program total about US$369.7 million, against a US$1 billion authorization.
- The 2025 Repurchase Program was authorized as of July 15, 2025 and covers Nasdaq-listed Class A and Class B common stock; no ASX-listed CDIs will be repurchased.
- The buy-back is conducted in US dollars and is not subject to security holder approval.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.